Skip to main navigation

Overview
News & Events
- Press Releases
- Events
Regulated Information
Share Information
Key Documents
Corporate Governance
- Governance Overview
- Committee Composition
Investor Relations

Key Documents

Key Documents

Documents

Corporate Presentation | February 2021 3.3 MB

Form 20-F 2.5 MB

Document d’Enregistrement Universel for the year 2019 (April 2020) 7.9 MB

Latest Financial Results

Feb 24, 2021

Number of shares and voting rights of Innate Pharma as of February 1, 2021

Nov 17, 2020

Innate Pharma reports third quarter 2020 financial results and business update

Sep 08, 2020

Innate Pharma reports first half 2020 financial results and business update

May 12, 2020

Innate Pharma First Quarter 2020 Report

Mar 10, 2020

Innate Pharma Reports Full Year 2019 Financial Results and Business Update

Nov 13, 2019

Innate Pharma third quarter 2019 report

Sep 13, 2019

Innate Pharma reports first half 2019 financial results and business update

May 15, 2019

Innate Pharma First Quarter 2019 Report

Mar 20, 2019

2018 financial results and business update: landmark deal with AstraZeneca to support transition into a fully integrated oncology-focused biotech, strong clinical progress in lead assets

Nov 15, 2018

Third quarter 2018 report

Print
Email Alerts
RSS Feeds
Search

© 2021 Innate Pharma